References and Notes
1a Batt DG. inventors; WO 2010009069.
1b Tjoeng FS, Carter J, Springer JR, and Zupec ME. inventors; WO 2006040676A1.
1c
Cain J.
Nature
(London)
1960,
188:
774
1d
Torregroza I.
Evans T.
Das CB.
Chem.
Biol. Drug Des.
2009,
3:
339
1e
Fatome M.
Andrieu L.
Laval DJ.
Clavel MJ.
Blanco L.
Guillaumel J.
Rene L.
Royer R.
Eur. J. Med. Chem.
1977,
383
2a
Ramón DJ.
Yus M.
Angew.
Chem. Int. Ed.
2005,
44:
1602
2b
Zhu J.
Eur.
J. Org. Chem.
2003,
1133
2c
Ugi I.
Domling A.
Werner B.
J.
Heterocycl. Chem.
2000,
37:
647
2d
Bienayme H.
Hulme C.
Oddon G.
Schmitt P.
Chem. Eur. J.
2000,
6:
3321
2e
Shinu VS.
Sheeja B.
Purushothaman E.
Bahulayan D.
Tetrahedron
Lett.
2009,
50:
4838
2f
Arabanian A.
Mohammadnejad M.
Balalaie S.
Gross JH.
Bioorg. Med. Chem.
Lett.
2009,
19:
887
2g
Chebanov VA.
Muravyova EA.
Desenko SM.
Musatov VI.
Knyazeva IV.
Shishkina SV.
Shishkin OV.
Kappe CO.
J. Comb. Chem.
2006,
8:
427
2h
Dondoni A.
Massi A.
Sabbatini S.
Bertolasi V.
J. Org. Chem.
2002,
67:
6979
2i
Rashinkar G.
Salunkhe R.
J. Mol. Catal. A: Chem.
2010,
316:
146
2j
Srihari P.
Singh VK.
Bhunia DC.
Yadav JS.
Tetrahedron
Lett.
2009,
50:
3763
3
Hafez EA.
Elnagdi MH.
Elagamey AGA.
El-Taweel FMAA.
Heterocycles
1987,
26:
903
4a
Limsuwan S.
Trip EN.
Kouwen TRMH.
Piersma S.
Hiranrat A.
Mahabusarakam W.
Voravuthikkunchai SP.
Maarten von Dijl J.
Kayser O.
Phytomedicine
2009,
16:
645
4b
Bowers WS.
Ohta T.
Cleere JS.
Marsella PA.
Science
1976,
193:
542
5a
Skommer J.
Wlodkowic D.
Mattö M.
Eray M.
Pelkonen J.
Leukemia Res.
2006,
30:
322
5b
Rossi A.
Di Paola R.
Mazzon E.
Genovese T.
Caminiti R.
Bramanti P.
Pergola C.
Koeberle A.
Werz O.
Sautebin L.
Cuzzocrea S.
J.
Pharmacol.
2008,
329:
76
6
Hiramoto J.
Nasuhara A.
Michiloshi K.
Kato T.
Kikugawa K.
Mutat.
Res.
1997,
395:
47
7
Bianchi G.
Tava A.
Agric. Biol. Chem.
1987,
51:
20
For reviews on indium Lewis acids,
see:
8a
Frost CG.
Chauhan KK.
J.
Chem. Soc., Perkin Trans. 1
2000,
3015
8b
Fringuelli F.
Piermatti O.
Pizzo F.
Vaccaro L.
Curr. Org. Chem.
2003,
7:
1661
8c
Frost CG.
Hartley JP.
Mini-Rev.
Org. Chem.
2004,
1:
1
9a
Jayashree P.
Shanthi G.
Perumal PT.
Synlett
2009,
917
9b
Shanthi G.
Perumal PT.
Tetrahedron Lett.
2007,
48:
6785
9c
Babu TH.
Perumal PT.
Synlett
2011,
341
9d
Shanthi G.
Perumal PT.
Synlett
2008,
2791
10a
Thirumurugan P.
Perumal PT.
Tetrahedron
Lett.
2009,
50:
4145
10b
Thirumurugan P.
Nandakumar A.
Muralidharan D.
Perumal PT.
J. Comb. Chem.
2010,
12:
161
11
Lakshmi NV.
Thirumurugan P.
Perumal PT.
Tetrahedron
Lett.
2010,
51:
1064
12
Lakshmi NV.
Thirumurugan P.
Jayakumar C.
Perumal PT.
Synlett
2010,
955
13a
Thirumurugan P.
Perumal PT.
Tetrahedron
2009,
65:
7620
13b
Praveen C.
Karthikeyan K.
Perumal PT.
Tetrahedron
2009,
65:
9244
14
Lakshmi NV.
Thirumurugan P.
Norrulla KM.
Perumal PT.
Bioorg. Med. Chem.
Lett.
2010,
20:
5054
15a
Babu G.
Perumal PT.
Aldrichimica
Acta
2000,
33:
16
15b
Babu G.
Perumal PT.
Tetrahedron Lett.
1997,
38:
5025
15c
Babu G.
Perumal PT.
Tetrahedron
1998,
54:
1627
15d
Babu G.
Nagarajan R.
Natarajan R.
Perumal PT.
Synthesis
2000,
661
15e
Shanthi G.
Subbulakshmi G.
Perumal PT.
Tetrahedron
2007,
63:
2057
16
Experimental Procedure
for the Synthesis of 2-Amino-4
H
-chromene 4a (Table 2, Entry 1)
To
a stirred mixture of salicylaldehyde 1 (1
mmol) and malononitrile (2, 1 mmol) in
EtOH, 3-methyl-1-phenyl-1H-pyrazol-5
(4H)-one (3,
1 mmol) and InCl3 (20 mol%) were added. The
reaction mixture was stirred until complete conversion of the product
as indicated by TLC (Table
[²]
).
The solid formed was filtered, dried, and recrystallized from EtOH
to obtain the pure product in good yield (85%) 4a.
2-Amino-4-(5-hydroxy-3-methyl-1-phenyl-1
H
-pyrazol-4-yl)-4
H
-chromene-3-carbonitrile
(4a, Table 2, Entry 1)
White solid; mp 150-152 ˚C.
IR (KBr): νmax = 3418, 3328, 3072,
2185, 1587 cm-¹. ¹H
NMR (500 MHz, DMSO-d
6): δ = 1.94
(s, 3 H), 2.04 (s, 1 H, OH, D2O exchangeable), 4.78 (s, 1
H), 6.78 (s, 2 H, NH2, D2O exchangeable),
6.96 (d, 1 H, J = 8.4
Hz), 7.01-7.06 (m, 2 H), 7.14-7.17 (m, 2 H), 7.38
(t, 2 H, J = 8.0
Hz), 7.68 (d, 2 H, J = 8.4
Hz). ¹³C NMR (125 MHz, DMSO-d
6): δ = 29.2,
31.2, 54.6, 115.8, 116.1, 119.1, 119.5, 121.2, 121.4, 123.2, 125.2,
125.5, 128.5, 129.4, 147.5, 149.1, 160.9. MS: m/z = 344.5 [M+].
Anal. Calcd (%) for C20H16N4O2:
C, 69.76; H, 4.68; N, 16.27. Found: C, 69.70; H, 4.72; N, 16.23.
17
2-Amino-8-ethoxy-4-(2-oxo
indolin-3-yl)-4
H
-chromene-3-carbonitrile
(6b, Table 3, Entry 2)
White solid; mp 178-180 ˚C.
IR (KBr): νmax = 3614, 3189, 2183,
1698, 1583, 1476, 1422, 1334, 1269, 1217, 1076, 751 cm-¹. ¹H
NMR (500 MHz, DMSO-d
6): δ = 1.20
(t, 3 H, 6.9Hz), 3.58 (d, 1 H, 3.1 Hz), 3.86-3.93 (m, 2
H), 4.19 (d, 1 H, J = 3.1
Hz), 6.58 (d, 1 H, J = 7.7
Hz), 6.66 (d, 1 H, J = 7.7 Hz),
6.76 (d, 1 H, J = 8.4
Hz), 6.81 (t, 1 H, J = 6.9
Hz), 6.86 (t, 1 H, J = 7.7
Hz), 7.01 (t, 1 H, J = 7.7
Hz), 7.06 (s, 2 H, NH2, D2O exchangeable),
7.13 (d, 1 H, J = 7.7
Hz), 10.39 (s, 1 H, NH, D2O exchangeable). ¹³C
NMR (125 MHz, DMSO-d
6): δ = 15.03,
37.8, 52.9, 53.3, 64.7, 109.65, 113.3, 119.5, 121.2, 121.7, 124.2,
127.2, 128.6, 139.8, 143.5, 146.3, 162.4, 177.2. MS: m/z = 347.2 [M+].
Anal. Calcd (%) for C20H17N3O3:
C, 69.15; H, 4.93; N, 12.10. Found: C, 69.13; H, 4.90; N, 12.08.
18
2-Amino-8-methoxy-4-(4,4-dimethyl-2,6-dioxocyclo-hexyl)-4
H
-chromene-3-carbonitrile
(8h, Table 4, Entry 8)
White solid; mp 150-152 ˚C.
IR (KBr): νmax = 3336, 3162, 2209,
1704, 1635, 1508, 1390, 1028 cm-¹. ¹H
NMR (500 MHz, DMSO-d
6): δ = 1.05
(s, 3 H), 1.06 (s, 3 H), 2.48 (s, 2 H), 2.52 (s, 2 H), 3.72 (s,
3 H), 3.95 (d, 1 H, J = 3.1
Hz), 4.50 (d, 1 H, J = 3.1
Hz), 6.70-6.73 (m, 2 H), 7.17-7.19 (m, 1 H), 7.61
(s, 2 H, NH2, D2O exchangeable). ¹³C
NMR (125 MHz, DMSO-d
6): δ = 26.6,
27.0, 32.3, 55.9, 101.9, 109.2, 111.8, 112.2, 113.8, 117.5, 130.6,
151.6, 152.0, 160.3, 165.6, 168.4, 197.0. MS: m/z = 340.1 [M+].
Anal. Calcd (%) for C19H20N2O4:
C, 67.05; H, 5.92; N, 8.23. Found: C, 67.03; H, 5.86; N, 8.27.